×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ALEC – alector, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ALEC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/14
04:05 pm
alec
Alector Secures Flexible Credit Facility for Up to $50 Million From Hercules Capital
High
Report
Alector Secures Flexible Credit Facility for Up to $50 Million From Hercules Capital
11/7
08:36 am
alec
Alector, Inc. (NASDAQ: ALEC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $35.00 price target on the stock.
Low
Report
Alector, Inc. (NASDAQ: ALEC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $35.00 price target on the stock.
11/6
04:05 pm
alec
Alector Reports Third Quarter 2024 Financial Results and Provides Business Update
Medium
Report
Alector Reports Third Quarter 2024 Financial Results and Provides Business Update
9/19
08:00 am
alec
Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)
Medium
Report
Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)
9/17
11:04 am
alec
Alector, Inc. (NASDAQ: ALEC) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Medium
Report
Alector, Inc. (NASDAQ: ALEC) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
9/9
01:03 pm
alec
Alector, Inc. (NASDAQ: ALEC) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Medium
Report
Alector, Inc. (NASDAQ: ALEC) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
8/29
07:00 am
alec
Alector to Participate in Upcoming Healthcare Conferences
Medium
Report
Alector to Participate in Upcoming Healthcare Conferences
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
04:11 pm
alec
Form 8-K Alector, Inc. For: Nov 14
High
Report
Form 8-K Alector, Inc. For: Nov 14
11/12
07:22 pm
alec
Form SC 13G/A Alector, Inc. Filed by: Polaris Venture Partners VI, L.P.
Medium
Report
Form SC 13G/A Alector, Inc. Filed by: Polaris Venture Partners VI, L.P.
11/7
12:41 pm
alec
Form SC 13G/A Alector, Inc. Filed by: MORGAN STANLEY
Low
Report
Form SC 13G/A Alector, Inc. Filed by: MORGAN STANLEY
11/6
04:16 pm
alec
Form 10-Q Alector, Inc. For: Sep 30
Medium
Report
Form 10-Q Alector, Inc. For: Sep 30
11/6
04:10 pm
alec
Form 8-K Alector, Inc. For: Nov 06
Medium
Report
Form 8-K Alector, Inc. For: Nov 06
10/10
04:05 pm
alec
Form 4 Alector, Inc. For: Aug 02 Filed by: SCHELLER RICHARD H
Medium
Report
Form 4 Alector, Inc. For: Aug 02 Filed by: SCHELLER RICHARD H
10/2
04:06 pm
alec
Form 4 Alector, Inc. For: Oct 01 Filed by: GRASSO MARC
Medium
Report
Form 4 Alector, Inc. For: Oct 01 Filed by: GRASSO MARC
10/2
04:05 pm
alec
Form 4 Alector, Inc. For: Oct 01 Filed by: Kenkare-Mitra Sara
Medium
Report
Form 4 Alector, Inc. For: Oct 01 Filed by: Kenkare-Mitra Sara
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
2/5
Alector Announces FDA Fast Track Designation Granted to AL101 for the Treatment of Patients with Frontotemporal Dementia
12.0%
1/30 Form EFFECT Alector, Inc. 10.9%
1/8 Alector to Present at the J.P. Morgan 38th Annual Healthcare Conference 10.0%
4/28 Alector Inc (NASDAQ: ALEC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 8.9%
4/17 Form SC 13D/A Alector, Inc. Filed by: ORBIMED ADVISORS LLC 8.0%
2/3 Alector Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 7.1%
5/13 Q1/2019 3/31/2019 EPS -0.420 ZacksConsensus N/A ActVsEst N/A - N/A 6.2%
3/25 Alector Enters into a Licensing Agreement with Innovent Biologics to Develop and Commercialize AL008 in Oncology Indications in China 5.5%
9/9 Alector Initiates Phase 2 Trial of AL001 in Patients with Frontotemporal Dementia 4.7%
12/11 Alector Announces Appointment of Shehnaaz Suliman, M.D., MBA, M.Phil., as President and Chief Operating Officer 4.3%
1/30 Form EFFECT Alector, Inc. 10.9%
1/8 Alector to Present at the J.P. Morgan 38th Annual Healthcare Conference 10.0%
4/28 Alector Inc (NASDAQ: ALEC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 8.9%
4/17 Form SC 13D/A Alector, Inc. Filed by: ORBIMED ADVISORS LLC 8.0%
2/3 Alector Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 7.1%
5/13 Q1/2019 3/31/2019 EPS -0.420 ZacksConsensus N/A ActVsEst N/A - N/A 6.2%
3/25 Alector Enters into a Licensing Agreement with Innovent Biologics to Develop and Commercialize AL008 in Oncology Indications in China 5.5%
9/9 Alector Initiates Phase 2 Trial of AL001 in Patients with Frontotemporal Dementia 4.7%
12/11 Alector Announces Appointment of Shehnaaz Suliman, M.D., MBA, M.Phil., as President and Chief Operating Officer 4.3%
TOP News Decliners
3/30
Form 144 Alector, Inc. Filed by: ORBIMED ADVISORS LLC
-22.2%
2/7 Form 4 Alector, Inc. For: Feb 05 Filed by: Paul Robert -19.8%
3/23 Alector Announces the Appointment of Paula Hammond, Ph.D., to the Board of Directors -18.8%
3/17 Alector Inc (NASDAQ: ALEC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $26.00 price target on the stock. -11.1%
2/24 Alector to Present at the Cowen 40th Annual Health Care Conference -11.0%
4/2 Form 4 Alector, Inc. For: Mar 31 Filed by: ORBIMED ADVISORS LLC -8.8%
4/9 Form 144 Alector, Inc. Filed by: ORBIMED ADVISORS LLC -8.0%
12/8 Alector Inc (NASDAQ: ALEC) had its "buy" rating re-affirmed by analysts at Cowen Inc. -6.2%
3/4 Form 4 Alector, Inc. For: Mar 02 Filed by: OrbiMed Capital GP IV LLC -6.0%
1/27 Alector Announces Proposed Public Offering of Common Stock -5.4%
2/7 Form 4 Alector, Inc. For: Feb 05 Filed by: Paul Robert -19.8%
3/23 Alector Announces the Appointment of Paula Hammond, Ph.D., to the Board of Directors -18.8%
3/17 Alector Inc (NASDAQ: ALEC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $26.00 price target on the stock. -11.1%
2/24 Alector to Present at the Cowen 40th Annual Health Care Conference -11.0%
4/2 Form 4 Alector, Inc. For: Mar 31 Filed by: ORBIMED ADVISORS LLC -8.8%
4/9 Form 144 Alector, Inc. Filed by: ORBIMED ADVISORS LLC -8.0%
12/8 Alector Inc (NASDAQ: ALEC) had its "buy" rating re-affirmed by analysts at Cowen Inc. -6.2%
3/4 Form 4 Alector, Inc. For: Mar 02 Filed by: OrbiMed Capital GP IV LLC -6.0%
1/27 Alector Announces Proposed Public Offering of Common Stock -5.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: